Search By:
Products
Injury
Topic
Company
Industry
Merck drugs Fosamax may increase the risk of osteonecrosis of the jaw.
Investigation Source
- Nationwide
Investigation Scope
Category Information
Investigation Topic
- Increased Risk of Bodily Injury
Product or Service
- Fosamax
Injury Type
- Osteonecrosis
Investigation Details
Investigation and pending actions against for Fosamax-related injuries, including reports of osteonecrosis of the jaw.
Fosamax, marketed by Merck, is indicated for the treatment and prevention of osteoporosis (thinning of the bones) in men and women. Recent studies, however, suggest a link between the use of bisphosphonates, such as Fosamax, and osteonecrosis of the jaw, also known as 'jaw death.''
This condition is associated with the interference of the blood supply to the bone and the consequential damage that occurs. Osteonecrosis of the jaw can be extremely painful and may lead to additional complications, such as infection, breakdown of the jawbone, and ulcerations in the lining of the mouth. It is not known if discontinuing the use of Fosamax can lower the risk of osteonecrosis of the jaw, because the bisphosphonate medications metabolize slowly and remain in the bones for many years.
Do not change medications without first consulting your doctor.
Fosamax, marketed by Merck, is indicated for the treatment and prevention of osteoporosis (thinning of the bones) in men and women. Recent studies, however, suggest a link between the use of bisphosphonates, such as Fosamax, and osteonecrosis of the jaw, also known as 'jaw death.''
This condition is associated with the interference of the blood supply to the bone and the consequential damage that occurs. Osteonecrosis of the jaw can be extremely painful and may lead to additional complications, such as infection, breakdown of the jawbone, and ulcerations in the lining of the mouth. It is not known if discontinuing the use of Fosamax can lower the risk of osteonecrosis of the jaw, because the bisphosphonate medications metabolize slowly and remain in the bones for many years.
Do not change medications without first consulting your doctor.
Defendant Details
| Name (Stock Symbol) | Brief Description |
|---|---|
| Merck & Co. Inc. (MRK) | Merck & Co. Inc. is a large pharmaceutical company. |